NGS and personalized medicine: The role of data interpretation
The advance of Next Generation Sequencing technology has enabled researchers to generate genome wide data in unprecedented quality and quantity. Genomatix offers solutions and services for the entire course of analysis from first level mapping to integrating multiple results with copious high-quality data background. Our technologies for visualization and interpretation enable scientists world-wide to turn their data into meaningful results, making NGS the perfect vehicle to enable personalized medicine
-
Genomatix is a partner in the €30M European BLUEPRINT epigenomics consortium. Genomatix will provide data analysis and develop visualization interfaces for the recently started BLUEPRINT project.
» read more -
Genomatix now offers comprehensive NGS data analysis services.
For detailed information visit www.mygenomatix.com or follow the link below to our press release.
» read more -
Genomatix will be at the 2012 NIH Spring Research Festival Exhibit on April 25th-26th in Bethesda (US).
Meet us at booth #532!
» official page
